Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Extensive Stage Lung Small Cell Carcinoma × Lamivudine × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 1 Glioma 1 Extensive Stage Lung Small Cell Carcinoma 1

Interventions

atezolizumab 3 Etoposide 2 Carboplatin 2 lipoarabinomannan 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Magnetic Resonance Spectroscopy 1 Lamivudine 1 LB100 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04696575 2025-12-15

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2 Recruiting

Extensive Stage Lung Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡